As has been the case with other high-profile cabinet picks, Donald Trump appears to be considering at least one figure who is highly unconventional and distrusted by the establishment for the head of the FDA.
NBC reports Trump is pondering Jim O’Neill, who is a longtime colleague of PayPal billionaire Peter Thiel, a major Trump backer. O’Neill, like Thiel, describes himself as a libertarian and has said the FDA should have far less ability to restrict new drugs from entering the market before their safety and effectiveness has been judged.
Even the pharmaceutical industry would likely be skeptical of a vehemently anti-regulation FDA chief, says Michael Gaba, who works on health care policy for Holland & Knight, in an interview with NBC.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.